Plerixafor Complete Side Effect Guide: Adverse Reaction Classification and Professional Management

       Side Effect Overview

　　While plerixafor effectively increases the number of peripheral blood hematopoietic stem cells to support autologous hematopoietic stem cell transplantation,it may cause adverse reactions of varying degrees.Not all patients will experience side effects,and most reactions are mild to moderate and resolve spontaneously after treatment completion.However,some serious side effects can be life-threatening and require prompt recognition and medical intervention.

　　Serious Side Effects Requiring Immediate Medical Attention

　　If you experience any of the following symptoms,contact a healthcare professional immediately or go to the emergency department:

　　Common Serious Side Effects

　　Bleeding-related symptoms:Gum bleeding,hemoptysis,abnormally heavy menstrual bleeding,abnormal vaginal bleeding,nosebleeds,prolonged bleeding from wounds,red or black tarry stools,red or dark brown urine,subcutaneous hematoma,deep dark purple bruises

　　Neurological symptoms:Burning sensation,crawling sensation,itching,numbness,tingling("pins and needles")or prickling sensation,headache,dizziness,paralysis

　　Allergy-related symptoms:Difficulty breathing or swallowing,urticaria or hives,skin itching,rash,skin flushing or redness,abnormally warm skin,induration(hard lumps)at the injection site

　　Systemic symptoms:Feverish feeling,body swelling

　　Rare Serious Side Effects

　　Cardiovascular and circulatory system:Chest tightness,rapid heartbeat,cold sweats,fainting,myocardial infarction(heart attack)

　　Nervous system:Confusion,severe dizziness,lightheadedness or vertigo when getting up from a lying or sitting position

　　Allergic reactions:Swelling around the eyes

　　Systemic symptoms:Chills,severe weakness

　　Mild to Moderate Side Effects Usually Not Requiring Emergency Treatment

　　The following side effects usually disappear as your body adjusts to the medication.If symptoms persist,worsen,or bother you,consult a healthcare professional:

　　Common Mild to Moderate Side Effects

　　Gastrointestinal symptoms:Feeling of fullness,diarrhea,excessive gas in the stomach and intestines,nausea,flatulence,vomiting

　　Musculoskeletal symptoms:Difficulty moving,joint pain,muscle pain or stiffness

　　Psychiatric symptoms:Difficulty falling asleep(insomnia)

　　Less Common Mild to Moderate Side Effects

　　Gastrointestinal symptoms:Belching,difficulty passing stools,dry mouth,heartburn,indigestion,pressure in the stomach,stomach discomfort or upset,swelling of the abdomen or stomach area

　　Systemic symptoms:Bone pain,general feeling of discomfort or illness,increased sweating

　　Systematic Side Effect Management for Healthcare Professionals

　　The following data are based on global multicenter clinical trials and long-term post-marketing surveillance,presented by system organ class:

　　Gastrointestinal Adverse Events

　　Very common(incidence≥10%):Diarrhea(up to 37%),nausea(up to 34%),vomiting(up to 10%)

　　Common(incidence 1%-10%):Flatulence,abdominal pain,abdominal distension,dry mouth,stomach discomfort,oral hypoesthesia,constipation,indigestion

　　Management recommendations:Mild to moderate gastrointestinal reactions can be relieved by dietary adjustments and symptomatic use of antiemetics or antidiarrheals.Severe reactions require assessment of dehydration and electrolyte imbalance,and temporary discontinuation with supportive treatment if necessary.

　　Local Reactions

　　Very common(incidence≥10%):Injection site reactions(up to 34%),including pain,erythema,induration,swelling,itching,etc.

　　Management recommendations:Most injection site reactions are mild to moderate and do not require special treatment.Severe local reactions can be treated with cold compresses or topical corticosteroids.

　　Systemic Reactions

　　Very common(incidence≥10%):Fatigue(up to 27%)

　　Common(incidence 1%-10%):Malaise

　　Management recommendations:Advise patients to get adequate rest and avoid strenuous activity.Severe fatigue requires assessment of the patient's overall nutritional status and comorbidities.

　　Neurological Reactions

　　Very common(incidence≥10%):Headache(up to 22%),paresthesia(up to 20.6%),dizziness(up to 11%)

　　Uncommon(incidence 0.1%-1%):Vasovagal reactions(such as presyncope or syncope)

　　Management recommendations:Paresthesia is usually transient and does not require special treatment.Headache can be treated symptomatically with non-steroidal anti-inflammatory drugs.If a vasovagal reaction occurs,immediately place the patient in a supine position with elevated legs and monitor vital signs.

　　Musculoskeletal Reactions

　　Very common(incidence≥10%):Arthralgia(up to 13%)

　　Common(incidence 1%-10%):Musculoskeletal pain

　　Management recommendations:Mild to moderate pain can be treated symptomatically with non-steroidal anti-inflammatory drugs.Severe pain requires assessment for other etiologies such as bone metastases.

　　Skin Reactions

　　Common(incidence 1%-10%):Hyperhidrosis,erythema

　　Management recommendations:Most skin reactions are mild to moderate and do not require special treatment.Severe rashes require exclusion of allergic reactions and appropriate treatment.

　　Hematological Reactions

　　Common(incidence 1%-10%):Leukocytosis

　　Frequency not reported:Thrombocytopenia

　　Post-marketing reports:Splenomegaly and splenic rupture

　　Management recommendations:Monitor complete blood count daily during treatment.Closely monitor respiratory and circulatory status in patients with leukocytosis.Inform patients to seek immediate medical attention if they experience left upper abdominal pain or left shoulder pain,as these may indicate splenic rupture.

　　Psychiatric Reactions

　　Common(incidence 1%-10%):Insomnia

　　Uncommon(incidence 0.1%-1%):Abnormal dreams,nightmares

　　Management recommendations:Insomnia can be treated symptomatically with short-acting sedative-hypnotics.Severe psychiatric symptoms require assessment for discontinuation of treatment.

　　Immune System Reactions

　　Uncommon(incidence 0.1%-1%):Hypersensitivity reactions

　　Post-marketing reports:Anaphylactic reactions,including anaphylactic shock

　　Management recommendations:Obtain a detailed allergy history before administration.Monitor patients closely in a healthcare setting for at least 30 minutes after dosing.Discontinue treatment immediately if a hypersensitivity reaction occurs and administer antihistamines,corticosteroids,etc.Follow emergency protocols for anaphylactic shock.

　　Cardiovascular Reactions

　　Rare(incidence<0.1%):Myocardial infarction

　　Management recommendations:Closely monitor electrocardiogram and cardiac enzymes in patients with a history of cardiovascular disease.Discontinue treatment immediately and perform relevant investigations if chest pain,chest tightness,or other symptoms occur.

　　Important Safety Precautions

　　Splenomegaly and splenic rupture:Plerixafor may cause splenomegaly and even life-threatening splenic rupture.Immediate imaging evaluation is required if patients present with left upper abdominal pain,left shoulder pain,or abdominal distension.

　　Anaphylactic shock:Fatal anaphylactic shock has been reported post-marketing.Emergency equipment and medications must be available at the administration site.

　　Leukocytosis:White blood cell counts may increase significantly after treatment.Enhanced monitoring is required when white blood cell counts exceed 50×10⁹/L.